FA vs GILD · P/E 318, rev $860.2M vs P/E 18, rev $29.44B
First Advantage Corp (FA) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
First Advantage Corp (FA) is a specialty business services company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported FA revenue for 2024-12-31 was $860.2M. Net income was -$110.3M. Revenue was up 12.6% from 2023-12-31 to 2024-12-31. FA currently screens at market cap $2.72B and trailing P/E 317.6.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
FA currently screens at market cap $2.72B and trailing P/E 317.6. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the FA and GILD stock pages for the full models.
Not investment advice.